Cardiovascular Medicine
Showing 81-100 of 126 Results
-
Alexander C. Perino
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioAlexander C. Perino, MD is a cardiac electrophysiologist at Stanford Health Care whose primary focus is providing procedural care for patients with heart rhythm disorders. He performs a wide range of ablation and cardiac device implantation procedures, utilizing cutting-edge techniques and technologies to deliver high-quality, patient-centered care.
Dr. Perino serves as the Director of the Electrophysiology Laboratory at Stanford Health Care, where he leads efforts to enhance procedural quality, safety, and patient outcomes across the electrophysiology program. He is also the principal investigator for numerous clinical trials, working to ensure that patients have the opportunity to participate in research and contribute to scientific advancement—without compromising the quality of their care.
In addition, Dr. Perino is the Medical Informatics Director for the Division of Cardiovascular Medicine at Stanford Health Care. In this role, he oversees initiatives aimed at improving the quality and safety of cardiovascular care, while optimizing the electronic health record to better support patients and clinicians alike. -
Jena Pizula, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Pizula is a quadruple board-certified, fellowship-trained cardiologist with Stanford Health Care Cardiovascular Health. She is also a clinical assistant professor in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine. She completed a fellowship in cardiovascular medicine at the University of Southern California (USC) Keck School of Medicine.
Dr. Pizula specializes in cardio-obstetrics. She works with women before, during, and after pregnancy to determine their risk of heart-related pregnancy complications and improve their cardiovascular health. She has experience managing complex cardiovascular conditions, including congenital heart disease, arrhythmias, coronary artery disease, valvular disease, and cardiomyopathy. Dr. Pizula develops a customized care plan for each patient she treats. As a leader in cardio-obstetrics, she’s at the forefront of the latest advances in women’s cardiovascular care.
Her research interests include the intersection of cardiovascular disease and pregnancy. She focuses on how pre-existing conditions like congenital heart disease, cardiomyopathy, or hypertension affect pregnancy. She has also explored how physiological changes during pregnancy affect existing heart disease and long-term cardiovascular risk. She uses her unique dual background in internal medicine and pediatrics to study how adult manifestations of cardiovascular disease impact pregnancy outcomes.
Dr. Pizula is active in teaching medical students, internal medicine and obstetrical residents, and cardiology fellows. She teaches them strategies to improve how they assess and manage risk and deliver postpartum care to people with high-risk cardiac pregnancies. Dr. Pizula is the director of the Finishing School for Future Cardiologists for the California chapter of the American College of Cardiology, which offers leadership development to cardiology fellows.
Dr. Pizula’s research has been published in the Journal of the American Heart Association, Journal of the American College of Cardiology, The Journal of Heart and Lung Transplantation, Journal of General Internal Medicine, and Pediatrics. She has authored three book chapters on cardio-obstetrics and global emergency medicine.
Dr. Pizula has presented her research at conferences in the United States and internationally. As an expert in cardiovascular disease and pregnancy, she is frequently invited to speak to cardiologists, obstetricians, and anesthesiologists at the International Congress on Cardiac Problems in Pregnancy. She currently serves as a reviewer for the European Journal of Heart Failure and Heart Failure Reviews.
Dr. Pizula is a member of the American College of Cardiology, Stanford Medicine Cardiovascular Institute, and Stanford Medicine Maternal & Child Health Research Institute. -
Richard Popp
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsAcademic-Industrial relations; Ethics of invention.
-
Krishna Pundi
Clinical Instructor, Medicine - Cardiovascular Medicine
BioKrishna Pundi, MD is a cardiac electrophysiologist and health services and outcomes researcher with a clinical interest in the management of ventricular arrhythmias and atrial fibrillation.
Dr. Pundi leads a multidisciplinary research program to study (1) clinical and arrhythmia-specific factors that predict cardiovascular risk for ventricular arrhythmias, (2) the interplay of frailty and obesity with atrial fibrillation outcomes, and (3) the role of digital health and wearables in arrhythmia care. He has led grant-funded research through the NIH, FDA, and ACC and collaborations with large device and quality databases including AHA’s Get With the Guidelines. He has a special interest in innovation and regulatory science, having organized national Think Tanks of patients, investigators, and FDA to define the scientific and clinical use of wearable monitors. Dr. Pundi holds leadership roles through the American College of Cardiology, Heart Rhythm Society, Cardiovascular Sciences Research Consortium, and HRX - an innovation-focused meeting of clinicians, researcher, and industry. -
Thomas Quertermous, MD
William G. Irwin Professor of Cardiovascular Medicine
Current Research and Scholarly InterestsUnderstanding genetic basis of cardiovascular function and disease.
-
Sameer Raina, MD, MBBS, MBA, FACC
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioDr. Raina is a board-certified cardiologist in the General Cardiology clinic at Stanford Health Care and a member of the Stanford Cardiovascular Institute. He is also a clinical associate professor in the Division of Cardiovascular Medicine.
His clinical interests include preventive cardiology, cardiac rehabilitation, and sports cardiology. In his recent positions at West Virginia University, he established the cardiology telemedicine program during and after the COVID pandemic. He applied his passion for cardiac rehab by creating individualized treatment plans for college athletes recovering from COVID. Dr. Raina is also passionate about building relationships with community doctors. He believes continuous communication is an essential part of excellent patient care.
Dr. Raina’s current research focuses on preventive cardiology, cardiac imaging, and outcomes research. He studies the outcomes of different cardiac interventions in specific patient populations. His research helps identify appropriate treatments for patients who have other conditions in addition to heart disease.
Dr. Raina eagerly anticipates joining the faculty of the Stanford South Asian Translational Heart Initiative (SSATHI). He is excited for the opportunity to address the high risk of cardiovascular diseases among South Asians. He looks forward to applying his clinical and research experience to support SSATHI’s mission to provide advanced care to ethnic populations disproportionately affected by these diseases.
Dr. Raina is a peer reviewer for several prestigious publications, including Neuropsychiatric Disease and Treatment and the International Journal of Chronic Obstructive Pulmonary Disease. He has also been an invited guest speaker at national and international meetings, including those for the International Congress of Cardiology and the World Congress of Cardiothoracic-Renal Diseases.
Dr. Raina is a fellow of the American College of Cardiology (FACC) and a member of the American College of Cardiology. -
Risheen Reejhsinghani
Clinical Associate Professor, Medicine - Cardiovascular Medicine
BioRisheen Reejhsinghani obtained her medical degree in Mumbai, India, followed by an internal medicine residency at St. Elizabeth's Medical Center in Boston, MA and cardiology fellowship at Baystate Medical Center/Tufts University School of Medicine, where she served as one of the chief fellows. She subsequently completed an advanced echocardiography fellowship at the University of California, San Francisco, and is board certified in echocardiography, general cardiology, and nuclear cardiology.
Dr. Reejhsinghani practices as a general cardiologist in the Division of Cardiovascular Medicine at Stanford University School of Medicine, where she also serves as the associate director for the hospital-based consultative cardiology service. As a clinical cardiologist, she believes strongly in the tenets of evidence-based practice, diagnostic cognizance, and patient education. She also has a specific interest in the burgeoning field of Cardio-Rheumatology, focused on cardiac diseases among patients with rheumatologic conditions such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and ankylosing spondylitis, among others. Her clinical research in this area has focused on the evaluation of structural cardiac disease and diastolic dysfunction in ankylosing spondylitis patients, primarily using echocardiography.
Dr. Reejhsinghani has an academic focus in medical education, and believes that instilling a love for bedside medicine and the physical exam is the soundest way to empower future generations of learners. To this end, she received additional training in clinical teaching and simulation at the University of California, San Francisco, and has worked extensively on curriculum and course design. She currently serves as the associate program director of the cardiovascular medicine fellowship at Stanford, and is an associate course director for the Year 1 Practice of Medicine Course at the Stanford University medical school. Dr. Reejhsinghani also enjoys writing, particularly about medical education and has written articles for international newspapers, among other publications. -
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.
-
Fatima Rodriguez
Associate Professor of Medicine (Cardiovascular Medicine)
BioFatima Rodriguez, MD, MPH serves as the Vice Chair of Clinical Research (Department of Medicine), Section Chief of Preventive Cardiology, and Associate Director of the Center for Digital Health at Stanford University. She received her medical degree from Harvard Medical School and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Dr. Rodriguez completed her internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford.
Dr. Rodriguez specializes in the prevention and management of cardiovascular disease, with clinical expertise in coronary artery disease and inherited lipid disorders. Her research focuses on cardiovascular disease prevention and health promotion, leveraging digital tools to improve guideline-based care, and using AI-enabled approaches for early detection of atherosclerosis. -
Albert "A.J." Rogers, MD, MBA, FAHA
Instructor, Medicine - Cardiovascular Medicine
BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is also an instructor of medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.
As a clinical cardiac electrophysiologist, Dr. Rogers’ training includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). His expertise includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.
Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.
As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 10 years of experience with medical technology innovation and development.
Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He is also a peer reviewer for multiple prestigious journals, including Heart Rhythm, The Lancet: Digital Health, the Journal of the American College of Cardiology: Clinical Electrophysiology, and Frontiers in Physiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society. -
Karim Sallam, MD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioKarim Sallam, MD, is trained in Cardiovascular Medicine and Advanced Heart Failure.
-
Ryan Sandoval, M.D.
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sandoval is a board-certified cardiologist and a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. He completed his residency at the University of Texas at Austin, where he continued on as chief resident before going on to complete his fellowship in cardiovascular disease at the Medical University of South Carolina. Prior to his residency, he completed a research fellowship at Massachusetts General Hospital (MGH).
His clinical interests include preventive cardiology and management of heart failure. He is particularly focused on treating patients with the complex clinical syndrome of heart failure with preserved ejection fraction (HFpEF).
His interest in preventive cardiology grew through his participation in clinics for the uninsured and underinsured during his training. These experiences fostered his passion for understanding and addressing health care disparities. He is deeply committed to providing exceptional patient care with a personalized approach to treatment and improving the lives of his patients.
He is a member of the American College of Cardiology. -
Ingela Schnittger, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.
-
John S. Schroeder, MD
Professor (Clinical) of Medicine (Cardiovascular), Emeritus
Current Research and Scholarly Interests1. Clinical Pharmocology of Cardiovascular Drugs
(a) Calcium Channel Blockers
(b) Agents for Heart Failure
(c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers
2. Cardiac Transplantation/Congestive Heart Failure
3. Coronary Artery Spasm -
Rahul P Sharma, MBBS, FRACP
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Joshua M. Spin
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsDr. Spin began his research career studying the structural biology of low density lipoprotein, and has had intensive training in molecular biology techniques, particularly high-throughput genetic expression profiling. He is especially interested in vascular smooth muscle cells, and the role of smooth muscle differentiation and phenotypic switching in development, and in vascular disease. His latest work has focused on the biology of aortic aneurysms.
-
Juwono L. Sutedjo, MD, MBA
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sutedjo is a board-certified, fellowship-trained cardiologist. She is a faculty in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Sutedjo holds seven board certifications. She specializes in complex cardiovascular conditions, emphasizing multimodality cardiovascular imaging and disease prevention. She integrates leading-edge diagnostics with evidence-based strategies to provide comprehensive, patient-centered care. She has led multidisciplinary clinics, telehealth programs, and ambulatory operations to enhance accessibility and efficiency.
Dr. Sutedjo has a visionary approach to the future of cardiovascular medicine, particularly in the context of the rapidly evolving digital era. With a clear understanding of the need for innovative business models in healthcare, she pursued an MBA from the Wharton School of the University of Pennsylvania to complement her medical expertise. As a physician executive and clinical researcher, she has deep expertise in clinical operations, health care delivery, and finance. Her diverse background spans private practice, integrated healthcare systems, and managed care settings, providing her with a comprehensive perspective on the healthcare landscape. Driven by a commitment to enhancing patient outcomes, Dr. Sutedjo is deeply invested in leveraging digital health innovations and artificial intelligence to advance the field of cardiovascular care.
Dr. Sutedjo’s research explores AI, machine learning, and digital health applications in cardiovascular risk prediction, diagnosis, and treatment. She aims to improve efficiency, reduce disparities, and enhance precision in clinical decision-making.
Dr. Sutedjo has published her work in Circulation, The American Journal of Medicine, and 21st Century Cardiology. She has also presented at the American Heart Association Scientific Sessions and other national and international conferences, engaging with industry leaders and private sector stakeholders on the role of AI in health care. She has co-founded several health technology startups and served as a consultant for leading technology companies and private sector organizations. Additionally, she played a key role in the IPO of a tech startup on the Toronto Stock Exchange.
